Table 3 The prognostic value of FNDC3B (Overall Survival) in subgroups of patients with pancreatic cancer
Characteristics | Total (N) | HR (95% CI) | P value |
|---|---|---|---|
T stage | |||
 T1 & T2 | 31 | 1.416 (0.433–4.635) | 0.5435 |
 T3 & T4 | 145 | 1.468 (0.951–2.265) | 0.0803 |
N stage | |||
 N0 | 50 | 1.495 (0.593–3.768) | 0.3873 |
 N1 | 123 | 1.078 (0.681–1.706) | 0.7470 |
M stage | |||
 M0 | 79 | 1.566 (0.860–2.854) | 0.1470 |
 M1 | 5 | – | – |
Radiation therapy | |||
 No | 118 | 1.893 (1.176–3.046) | 0.0096 |
 Yes | 45 | 1.249 (0.476–3.276) | 0.6381 |
Primary therapy outcome | |||
 PD & SD | 58 | 1.200 (0.673–2.138) | 0.5306 |
 PR & CR | 81 | 1.835 (0.906–3.717) | 0.0912 |
Gender | |||
 Female | 80 | 1.239 (0.695–2.209) | 0.4661 |
 Male | 98 | 2.178 (1.222–3.883) | 0.0064 |
Race | |||
 White | 157 | 1.760 (1.133–2.733) | 0.0096 |
 Asian & Black or African American | 17 | 0.894 (0.217–3.677) | 0.8643 |
Age | |||
 ≤ 65 | 93 | 2.376 (1.322–4.269) | 0.0029 |
 > 65 | 85 | 1.186 (0.670–2.101) | 0.5524 |
Residual tumor | |||
 R0 | 107 | 1.494 (0.863–2.588) | 0.1528 |
 R1 & R2 | 57 | 1.398 (0.711–2.748) | 0.3227 |
Histologic grade | |||
 G1 & G2 | 126 | 1.925 (1.162–3.189) | 0.0099 |
 G3 & G4 | 50 | 1.193 (0.583–2.443) | 0.6201 |
Anatomic neoplasm subdivision | |||
 Head of pancreas | 138 | 1.284 (0.828–1.991) | 0.2604 |
 Other | 40 | 4.631 (1.539–13.940) | 0.0098 |